how is compounded tirzepatide made to Treat Diabetes How to Compound Tirzepatide: A

doi: 10.1038/s41591-022-02026-4 227 JensterleMRizzoMHaluzikMJanezA

Evidence for Kidney Benefits Clinical trials show consistent kidney benefits: FLOW trial (semaglutide): This dedicated kidney outcome trial showed semaglutide reduced the risk of major kidney outcomes (kidney failure, significant decline in kidney function, or kidney-related death) by 24% in diabetic patients with chronic kidney disease

A glance at the clinical trials on Victozas label confirms that the most common side effects for a 1.8 mg dose are nausea (20%), diarrhea (12%), headache (10%), nasopharyngitis (10%), vomiting (9%), and reduced appetite (9%)

TL;DR BPC 157 may help with injury recovery and inflammation reduction